THIRD DAY

Friday September 29th

TUMOR MICROENVIRONMENT

8.30-10.30 Session V:
François de KERMENGY/ Maria JOSÉ OLIVEIRA

8.30-9.00: Spatial transcriptomics reveals a substantial heterogeneity in TNBC tumor and stroma compartments with potential clinical implications
Pr Christos Sotiriou, Université Libre de Bruxelles , B


9.00-9.30: Immune contexture of radiation response
Dr Jerome Galon, Cordeliers Research Center, FR


9.30-10.00: Low Dose Radiotherapy: from the lab to the clinic
Dr Fernanda Herrera, Lausanne University Hospital, SW


10.00-10.30: Mapping of stromal heterogeneity and plasticity in breast cancer
Dr Fatima Mechta-Grigoriou, Institut Curie, FR


10.30-11.00 Coffee break

AI, IMAGING AND RADIOMICS

11.00-12.30 Session VI:
Nathan BENZAZON/ Maria VAKALOPOULOU

11.00-11.30: The role of standard imaging in radio-immunotherapy: focus on radiomics and lymphocyte sparing radiotherapy
Pr Philippe Lambin, Maastricht University, NL


11.30-12.00: Predictive and prognostic role of PET in immunotherapy
Dr Désirée Deandreis, Gustave Roussy, FR


12.00-12.30: Next generation radiotherapy at the era of AI and immunotherapy
Pr Eric Deutsch, Gustave Roussy, FR


12.30-14.00 Lunch break and exhibition

ADAPTIVE IMMUNITY

14.00-16.00 Session VII:
Marine FIDELLE/Carolina ALVES COSTA SILVA

14.00-14.30: Fatty Acid metabolic regulation of anti-tumor immunity against irradiated glioblastoma,
Dr Claire Vanpouille-Box, Weill Cornell Medicine, US


14.30-15.00: Human endogenous retroviruses represent a source of shared tumor epitopes  for cancer immunotherapy
Pr Stephane Depil, Centre Leon Berard, FR


15.00-15.30: Targeting IL2 signaling with radiotherapy to trigger systemic immunity
Pr Sana Karam, University of Colorado, USA


15.30-16.00: Impact of radiation on intestinal commensals and cancer immunosurveillance
Pr Laurence Zitvogel, Gustave Roussy, FR


16.00-16.30 Coffee break

INNATE IMMUNITY

16.30-18.00 Session VIII:
Lydia MEZIANI/Claudia FOURNIER

16.30-17.00: Clinical and Immune correlates of response to nivolumab plus chemoradiotherapy for locally-advanced cervical cancer – NiCOL study
Dr Emanuela Romano, Institut Curie, FR


17.00-17.30: The non-homogeneous administration of intratumor ionizing radiation doses synergizes with immune checkpoint and CXCR2 blockade
Dr Michele Mondini, Gustave Roussy, FR


17.30 -18.00: Photon and particle radiation innate immune response 
Pr Peter Hüber, German Cancer Research Center, G


19.30-00.00 GALA DINNER

 
Cookie Policy

This website uses cookies that are necessary to its functioning and required to achieve the purposes illustrated in the privacy policy. By accepting this OR scrolling this page OR continuing to browse, you agree to our privacy policy.

Cookie Policy